PT

Dados B3 › Restatements

Has MOVIDA PARTICIPAÇÕES S.A. (MOVI3) ever restated its financial statements? In which years?

Yes: the statements for 2014, 2015, 2016, 2018, 2022, 2024 came back with different figures in the following year's annual filing — 29 account(s) in all, each below with both values.

YearAccountAggregationAs first filedAs restatedDifferenceRevealed in (CVM file)
2014net operating cash flow (DFC_MI 6.01)consolidatedR$ 146.7 mR$ -19.7 m113.4%DFP 2015 · 01/04/2016
2014short-term borrowings (BPP 2.01.04)consolidatedR$ 75.8 mR$ 384.5 m80.3%DFP 2015 · 01/04/2016
2014income taxes (DRE 3.08)consolidatedR$ -970 kR$ -613 k36.8%DFP 2015 · 01/04/2016
2014profit before taxes (DRE 3.07)consolidatedR$ 5.7 mR$ 3.6 m36.8%DFP 2015 · 01/04/2016
2014profit from continuing operations (DRE 3.09)consolidatedR$ 4.8 mR$ 3.0 m36.8%DFP 2015 · 01/04/2016
2014operating profit (EBIT) (DRE 3.05)consolidatedR$ 10.7 mR$ 8.6 m19.5%DFP 2015 · 01/04/2016
2014gross profit (DRE 3.03)consolidatedR$ 21.0 mR$ 18.9 m10.1%DFP 2015 · 01/04/2016
2014net revenue (DRE 3.01)consolidatedR$ 60.3 mR$ 55.3 m8.3%DFP 2015 · 01/04/2016
2014current assets (BPA 1.01)consolidatedR$ 240.4 mR$ 222.6 m7.4%DFP 2015 · 01/04/2016
2014cost of goods and services (DRE 3.02)consolidatedR$ -39.3 mR$ -36.4 m7.3%DFP 2015 · 01/04/2016
2014current liabilities (BPP 2.01)consolidatedR$ 572.1 mR$ 554.2 m3.1%DFP 2015 · 01/04/2016
2014total assets (BPA 1)consolidatedR$ 1.37 bnR$ 1.36 bn1.3%DFP 2015 · 01/04/2016
2014total liabilities (BPP 2)consolidatedR$ 1.37 bnR$ 1.36 bn1.3%DFP 2015 · 01/04/2016
2015profit from continuing operations (DRE 3.09)consolidatedR$ 47.6 mR$ 53.7 m11.4%DFP 2016 · 22/03/2017
2015profit before taxes (DRE 3.07)consolidatedR$ 64.4 mR$ 72.5 m11.2%DFP 2016 · 22/03/2017
2015income taxes (DRE 3.08)consolidatedR$ -16.8 mR$ -18.8 m10.5%DFP 2016 · 22/03/2017
2015short-term borrowings (BPP 2.01.04)consolidatedR$ 702.4 mR$ 715.5 m1.8%DFP 2016 · 22/03/2017
2015current liabilities (BPP 2.01)consolidatedR$ 1.12 bnR$ 1.13 bn1.2%DFP 2016 · 22/03/2017
2015current assets (BPA 1.01)consolidatedR$ 777.8 mR$ 782.1 m0.5%DFP 2016 · 22/03/2017
2016cost of goods and services (DRE 3.02)consolidatedR$ -1.45 bnR$ -1.39 bn4.3%DFP 2017 · 21/03/2018
2016net revenue (DRE 3.01)consolidatedR$ 1.89 bnR$ 1.83 bn3.3%DFP 2017 · 21/03/2018
2018internal changes in equity (DMPL 5.06)consolidatedR$ -75.0 mno value in the file—DFP 2019 · 10/03/2020
2018transactions with shareholders (DMPL 5.04)consolidatedR$ 304.6 mR$ 229.6 m24.6%DFP 2019 · 10/03/2020
2022profit in the statement of changes in equity (DMPL 5.05.01)consolidatedR$ 556.4 mno value in the file—DFP 2023 · 25/03/2024
2022net income plus OCI (DMPL 5.05)consolidatedR$ -36.2 mR$ -592.6 m93.9%DFP 2023 · 25/03/2024
2022closing equity (DMPL 5.07)consolidatedR$ 2.77 bnR$ 2.21 bn20.1%DFP 2023 · 25/03/2024
2022cost of goods and services (DRE 3.02)consolidatedR$ -5.99 bnR$ -5.69 bn5.0%DFP 2023 · 25/03/2024
2022net revenue (DRE 3.01)consolidatedR$ 9.60 bnR$ 9.30 bn3.1%DFP 2023 · 25/03/2024
2024profit attributable to controlling shareholders (DRE 3.11.01)consolidatedR$ 231.5 mno value in the file—DFP 2025 · 23/03/2026

How it is detected: each year appears twice at the CVM — in its own annual filing and as the comparative in the next one. A difference above 0.5% in a key account is recorded, never corrected silently. Only the aggregation the site publishes (consolidated, or individual when the company does not consolidate) counts. “No value in the file” means the account came empty (zero) in that CVM file. Descriptive, not investment advice.

MOVI3 — company page · all restatements in the base

Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 07:15 UTC. If this does not match /saude, you are reading a cached copy.

Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.

Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 07:15 UTC. If this does not match /saude, you are reading a cached copy.